4//SEC Filing
Bir Dawn Carter 4
Accession 0001209191-23-046282
CIK 0001358762other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:35 PM ET
Size
7.4 KB
Accession
0001209191-23-046282
Insider Transaction Report
Form 4
Bir Dawn Carter
VP, Chief Commercial Officer
Transactions
- Sale
Class A common stock
2023-08-16$168.33/sh−398$66,996→ 33,805 total - Sale
Class A common stock
2023-08-15$169.04/sh−807$136,413→ 34,203 total
Footnotes (3)
- [F1]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $169.00 to $169.06. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $168.28 to $168.49. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001688712
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:35 PM ET
- Size
- 7.4 KB